Salute e Benessere
Embla Medical hf: The Centers for Medicare & Medicaid Services (CMS) grants extended coverage in the U.S. for lower-limb active K2 amputee patients to access bionic prosthetic solutions
The finalized policy, which will take effect on 1 September 2024 , does not automatically create access for every person currently classified as a K2 amputee. Treating healthcare professionals will have to establish through medical documentation that a bionic knee (MPK or microprocessor-controlled knee) or other K3 knee would improve the patient's functional health outcomes, help them accomplish activities of daily living, and that lower-level knee options have been considered and ruled out. In addition, to provide a K2 patient with an MPK, clinicians must use knees with integrated stumble recovery.
In addition, the extended coverage may also grant these active K2 functional level amputees access to a compatible high active K3 foot solution as a complement to the bionic knee when certain coverage criteria are met.
Link to news from US Medicare https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39777
Head of Investor Relations
M: +45 5363 0134
E: ksindahl@emblamedical.com
VP of Corporate Communication
M: +354 664 1055
E: egeirsdottir@emblamedical.com
If you wish to receive Embla Medical press releases by e-mail, please register at http://www.emblamedical.com/investors
Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people`s mobility by providing prosthetics, neuro orthotics, bracing & supports and patient care through a global network of orthotic & prosthetic facilities. Embla Medical is committed to sustainable business practices renowned for positively impacting people`s health and well-being.
K2 amputees: K-levels are a rating system used by Medicare to indicate a person's rehabilitation potential. The system is a rating from 0 through 4 and it indicates a person's potential to use a prosthetic device if they had a device that worked well for them and they completed rehabilitation to use the device properly. K2 describes a "limited community ambulator" who has the ability (or potential) to traverse low level environmental barriers such as curbs, stairs, or uneven surfaces, while K3 and K4 amputees are unlimited community ambulators who can walk at different speeds and perhaps even engage in athletic activities(K4).
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/embla-medical-hf-/r/embla-medical-hf--the-centers-for-medicare---medicaid-services--cms--grants-extended-coverage-in-the,c4016728
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/embla-medical-hf-the-centers-for-medicare--medicaid-services-cms-grants-extended-coverage-in-the-us-for-lower-limb-active-k2-amputee-patients-to-access-bionic-prosthetic-solutions-302201018.html